Index RUT
P/E -
EPS (ttm) -4.12
Insider Own 4.34%
Shs Outstand 48.13M
Perf Week -7.14%
Market Cap 143.90M
Forward P/E -
EPS next Y -0.29
Insider Trans -2.34%
Shs Float 46.04M
Perf Month 10.54%
Income -197.80M
PEG -
EPS next Q -0.14
Inst Own 77.49%
Short Float 0.96%
Perf Quarter -32.35%
Sales 187.51M
P/S 0.77
EPS this Y -13700.00%
Inst Trans -4.62%
Short Ratio 4.48
Perf Half Y -26.17%
Book/sh 5.58
P/B 0.54
EPS next Y 93.00%
ROA -35.04%
Short Interest 0.44M
Perf Year -21.11%
Cash/sh 0.13
P/C 23.32
EPS next 5Y -
ROE -53.88%
52W Range 2.50 - 4.94
Perf YTD -0.33%
Dividend Est. -
P/FCF 4.70
EPS past 5Y -
ROI -61.27%
52W High -39.47%
Beta 1.58
Dividend TTM -
Quick Ratio 2.13
Sales past 5Y -8.29%
Gross Margin -4.37%
52W Low 19.60%
ATR (14) 0.17
Dividend Ex-Date May 09, 2019
Current Ratio 2.25
EPS Y/Y TTM -2665.23%
Oper. Margin -70.10%
RSI (14) 44.68
Volatility 4.76% 6.02%
Employees 733
Debt/Eq 0.22
Sales Y/Y TTM -47.86%
Profit Margin -105.49%
Recom 1.00
Target Price 4.20
Option/Short Yes / Yes
LT Debt/Eq 0.20
EPS Q/Q -2100.88%
Payout -
Rel Volume 0.35
Prev Close 3.08
Sales Surprise -15.22%
EPS Surprise -4900.00%
Sales Q/Q -38.40%
Earnings Nov 01 BMO
Avg Volume 98.73K
Price 2.99
SMA20 -3.84%
SMA50 -4.07%
SMA200 -15.76%
Trades
Volume 34,984
Change -2.92%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-30-19 Downgrade
Barclays
Overweight → Equal Weight
$6.50 → $3.50
Sep-11-19 Downgrade
Johnson Rice
Buy → Hold
Aug-05-19 Reiterated
Imperial Capital
Outperform
$18 → $10
Jun-07-19 Downgrade
Stephens
Overweight → Equal-Weight
$25 → $7
May-03-19 Reiterated
Imperial Capital
Outperform
$22 → $18
Mar-19-19 Downgrade
Credit Suisse
Outperform → Neutral
$33 → $17
Mar-18-19 Reiterated
Imperial Capital
Outperform
$30 → $24
Mar-18-19 Downgrade
Tudor Pickering
Buy → Hold
Jan-09-19 Reiterated
Imperial Capital
Outperform
$40 → $30
Jan-04-19 Upgrade
Tudor Pickering
Hold → Buy
Aug-24-18 Downgrade
Raymond James
Outperform → Mkt Perform
Jun-08-18 Reiterated
Piper Jaffray
Overweight
$35 → $52
May-30-18 Reiterated
Imperial Capital
Outperform
$37 → $46
Apr-11-18 Downgrade
Tudor Pickering
Buy → Hold
Mar-28-18 Reiterated
R. F. Lafferty
Buy
$36 → $42
Mar-01-18 Reiterated
Imperial Capital
Outperform
$30 → $33
Feb-28-18 Upgrade
Johnson Rice
Accumulate → Buy
Feb-27-18 Upgrade
Barclays
Equal Weight → Overweight
$19 → $30
Oct-20-17 Reiterated
Imperial Capital
Outperform
$20 → $24
Oct-05-17 Initiated
Jefferies
Hold
$18
Show Previous Ratings
Dec-17-24 04:58PM
Nov-07-24 07:00AM
Nov-02-24 03:04AM
01:34AM
(Thomson Reuters StreetEvents)
Nov-01-24 07:00AM
09:06AM
Loading…
Oct-31-24 09:06AM
Oct-29-24 03:40PM
Oct-28-24 08:00AM
Oct-21-24 07:00AM
Oct-03-24 07:00AM
Oct-01-24 04:15PM
Sep-19-24 07:00AM
Aug-09-24 07:00AM
Jul-29-24 08:00AM
Jul-22-24 04:15PM
09:52AM
Loading…
May-06-24 09:52AM
May-03-24 12:21AM
(Thomson Reuters StreetEvents)
May-02-24 12:56PM
10:12AM
07:00AM
Apr-22-24 04:15PM
Mar-04-24 09:17AM
Mar-01-24 11:31PM
(Thomson Reuters StreetEvents)
09:32AM
07:00AM
Feb-12-24 04:15PM
Dec-06-23 08:00AM
Nov-11-23 11:29AM
Nov-09-23 11:08PM
(Thomson Reuters StreetEvents)
09:53AM
07:00AM
Loading…
07:00AM
Nov-01-23 08:00AM
Oct-19-23 08:00AM
Aug-11-23 11:52PM
(Thomson Reuters StreetEvents)
-17.64%
08:00AM
Jul-20-23 04:15PM
Jul-07-23 10:21AM
Jun-16-23 03:23PM
Jun-15-23 08:00AM
Jun-07-23 07:13AM
May-27-23 08:57AM
May-04-23 08:17AM
Apr-27-23 04:01PM
Apr-21-23 06:35AM
Apr-19-23 08:30AM
Feb-27-23 10:46PM
Feb-26-23 07:27AM
Feb-24-23 06:52AM
(Thomson Reuters StreetEvents)
Feb-23-23 04:01PM
Feb-06-23 04:15PM
Jan-28-23 08:49AM
Jan-24-23 04:15PM
Jan-19-23 05:07PM
Jan-17-23 04:15PM
Dec-06-22 04:15PM
Nov-01-22 04:15PM
Oct-31-22 10:25AM
Oct-27-22 04:01PM
Oct-17-22 04:15PM
(PR Newswire) +7.14%
+7.18%
Sep-26-22 04:15PM
Aug-24-22 04:15PM
Aug-21-22 09:15AM
Jul-28-22 11:00PM
(Motley Fool) -8.08%
+21.76%
04:01PM
Jul-14-22 04:36PM
Jun-14-22 04:15PM
Jun-07-22 07:00AM
May-24-22 06:33AM
May-10-22 03:00PM
May-09-22 04:15PM
Apr-26-22 04:15PM
Mar-31-22 08:30AM
Mar-29-22 08:00AM
Mar-14-22 08:30AM
07:33AM
Mar-04-22 02:00PM
08:30AM
06:00AM
Feb-25-22 04:15PM
Dec-01-21 08:00AM
Nov-19-21 10:53AM
07:07AM
05:07AM
Nov-18-21 04:15PM
Nov-16-21 08:00AM
Nov-05-21 06:00AM
Nov-03-21 08:00AM
Oct-26-21 09:11AM
Oct-14-21 08:00AM
Oct-01-21 08:00AM
Sep-28-21 02:25PM
Jul-30-21 11:31AM
06:00AM
Jul-29-21 04:15PM
Jul-23-21 06:00AM
Jun-29-21 08:37AM
Jun-08-21 07:00AM
Apr-29-21 08:31PM
04:01PM
Apr-23-21 04:32PM
Mammoth Energy Services, Inc. engages in the exploration and development of North American onshore unconventional oil and natural gas reserves. It operates through the following segments: Well Completion, Infrastructure, Sand, Drilling, and All Other. The Well Completion segment focuses on hydraulic fracturing and water transfer services primarily in the Utica Shale of Eastern Ohio, Marcellus Shale in Pennsylvania, and the mid-continent region. The Infrastructure segment offers electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities and co-operative utilities in the northeastern, southwestern, midwestern, and western portions of the United States. The Sand segment is involved in mining, processing, and sale of sand for use in hydraulic fracturing. The Drilling segment includes contract land and directional drilling services primarily in the Permian Basin and mid-continent region. The company was founded on June 3, 2016 and is headquartered in Oklahoma City, OK.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Amron Arthur H Director Dec 12 '24 Buy 2.97 1,000 2,971 47,135 Dec 16 05:02 PM Booker Corey J. Director Nov 25 '24 Sale 3.47 15,000 52,050 125,488 Nov 26 06:04 PM Booker Corey J. Director Nov 22 '24 Sale 3.43 10,000 34,300 140,488 Nov 26 06:04 PM Booker Corey J. Director Nov 21 '24 Sale 3.25 6,709 21,804 150,488 Nov 22 04:03 PM Booker Corey J. Director Nov 20 '24 Sale 3.21 5,000 16,050 157,197 Nov 22 04:03 PM Booker Corey J. Director Nov 13 '24 Sale 3.68 7,100 26,100 165,804 Nov 15 04:01 PM Booker Corey J. Director Nov 14 '24 Sale 3.50 3,607 12,624 162,197 Nov 15 04:01 PM Booker Corey J. Director Nov 11 '24 Sale 3.61 3,494 12,613 172,904 Nov 12 06:09 PM Booker Corey J. Director Nov 07 '24 Sale 3.90 165 644 176,422 Nov 12 06:09 PM Booker Corey J. Director Nov 08 '24 Sale 3.76 24 90 176,398 Nov 12 06:09 PM Booker Corey J. Director Nov 07 '24 Proposed Sale 3.86 64,767 250,001 Nov 07 05:20 PM Amron Arthur H Director May 30 '24 Buy 3.65 3,000 10,944 18,279 May 30 04:25 PM Amron Arthur H Director May 28 '24 Buy 3.57 2,000 7,148 15,279 May 30 04:25 PM Amron Arthur H Director Mar 12 '24 Buy 3.72 3,000 11,157 13,279 Mar 14 04:11 PM
Index -
P/E -
EPS (ttm) -0.09
Insider Own 12.87%
Shs Outstand 10.54M
Perf Week -1.18%
Market Cap 17.61M
Forward P/E 83.50
EPS next Y 0.02
Insider Trans 0.00%
Shs Float 9.19M
Perf Month 12.08%
Income -0.93M
PEG -
EPS next Q -0.01
Inst Own 40.64%
Short Float 0.08%
Perf Quarter 19.70%
Sales 13.55M
P/S 1.30
EPS this Y 73.33%
Inst Trans -0.82%
Short Ratio 0.77
Perf Half Y -24.09%
Book/sh 0.78
P/B 2.15
EPS next Y 150.00%
ROA -8.72%
Short Interest 0.01M
Perf Year -53.35%
Cash/sh 0.23
P/C 7.16
EPS next 5Y -
ROE -11.06%
52W Range 1.36 - 3.83
Perf YTD 13.61%
Dividend Est. -
P/FCF -
EPS past 5Y 21.13%
ROI -9.96%
52W High -56.40%
Beta 1.20
Dividend TTM -
Quick Ratio 4.02
Sales past 5Y 10.64%
Gross Margin 59.92%
52W Low 22.41%
ATR (14) 0.07
Dividend Ex-Date -
Current Ratio 6.95
EPS Y/Y TTM 50.48%
Oper. Margin -7.09%
RSI (14) 58.40
Volatility 3.17% 3.65%
Employees 31
Debt/Eq 0.18
Sales Y/Y TTM 0.03%
Profit Margin -6.86%
Recom 1.00
Target Price 4.75
Option/Short No / Yes
LT Debt/Eq 0.14
EPS Q/Q 200.00%
Payout -
Rel Volume 2.19
Prev Close 1.70
Sales Surprise 0.54%
EPS Surprise 200.00%
Sales Q/Q -5.99%
Earnings Nov 07 AMC
Avg Volume 9.30K
Price 1.67
SMA20 5.17%
SMA50 6.65%
SMA200 -9.39%
Trades
Volume 20,321
Change -1.76%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-26-21 Initiated
B. Riley Securities
Buy
$12.50
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
09:10AM
Loading…
Oct-25-24 09:10AM
Oct-24-24 09:00AM
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
01:01PM
Loading…
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
04:15PM
Loading…
Mar-08-23 04:15PM
(GlobeNewswire) -6.60%
-9.73%
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
(GlobeNewswire) +6.78%
-40.59%
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Apr-05-21 07:30AM
Mar-16-21 07:45AM
Mar-10-21 07:30AM
Mar-04-21 02:07AM
Mar-01-21 04:15PM
02:30PM
Feb-22-21 07:30AM
Feb-18-21 07:30AM
Jan-22-21 02:21AM
Jan-12-21 07:30AM
Jan-05-21 10:55AM
Jan-04-21 07:30AM
Nov-29-20 09:33AM
Nov-19-20 06:45AM
Nov-09-20 07:30AM
Nov-05-20 04:27PM
02:30PM
Oct-29-20 07:30AM
Oct-24-20 10:47AM
Oct-16-20 07:30AM
Oct-13-20 07:30AM
Oct-07-20 07:30AM
Oct-06-20 07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Amron Arthur H Director May 30 '24 Buy 2.24 3,000 6,735 103,463 May 30 04:35 PM Amron Arthur H Director May 28 '24 Buy 2.22 2,000 4,441 100,463 May 30 04:35 PM Banks Robert R. Jr. President and CEO May 16 '24 Buy 2.24 50,000 112,050 70,000 May 16 04:49 PM Amron Arthur H Director Mar 12 '24 Buy 2.45 7,000 17,130 7,000 Mar 14 04:28 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite